Cellular cholesterol homeostasis in vascular endothelial cells

Area of Science:

• Cardiovascular Biology
• Atherosclerosis Pathogenesis
• Endothelial Cell Metabolism

Background:

• Atherosclerosis initiates with endothelial insults, leading to inflammation and foam cell formation in macrophages and smooth muscle cells.
• Vascular endothelial cells (VECs) differ from macrophages in cholesterol accumulation during plaque development.
• VECs possess pathways for lipoprotein uptake and cholesterol synthesis, expressing receptors for oxidized lipoproteins.

Purpose of the Study:

• To investigate cholesterol homeostasis mechanisms in human endothelial cells.
• To identify genes and transporters involved in endothelial response to cholesterol loading.
• To compare cholesterol efflux pathways in VECs with those in macrophages.

Main Methods:

• Utilized gene expression microarrays to analyze differential gene expression post-cholesterol loading.
• Assessed cellular cholesterol efflux using high-density lipoproteins (HDL) and lipid-free apolipoprotein A-I.
• Stimulated VECs with liver X receptor agonist 22-hydroxycholesterol.

Main Results:

• High-density lipoproteins, but not apolipoprotein A-I, promoted cholesterol efflux in VECs.
• Identified ATP-binding cassette G1 (ABCG1) as a novel, highly expressed transporter in response to cholesterol loading and LXR activation.
• Observed weak expression of ABCA1, a major cholesterol efflux regulator in macrophages, in VECs.

Conclusions:

• Endothelial cells maintain cholesterol balance by decreasing cholesterol synthesis and LDL receptors, coupled with efflux onto HDL.
• The transporter ABCG1 is implicated in endothelial cholesterol homeostasis, warranting further investigation.
• Vascular endothelial cells utilize distinct cholesterol efflux mechanisms compared to macrophages.